Editorial: 365 days of progress in neuro-oncology and neurosurgical oncology

• Erik P. Sulman,
• Erik P. Sulman,
• Erik P. Sulman,
• Erik P. Sulman,
• David D. Eisenstat,
• David D. Eisenstat,
• David D. Eisenstat,
• David D. Eisenstat

Affiliations

Erik P. Sulman

Section of Neuro-oncology & Neurosurgical Oncology, Frontiers in Oncology and Frontiers in Neurology, Lausanne, Switzerland

Erik P. Sulman

Department of Radiation Oncology, NYU Grossman School of Medicine, New York, NY, United States

Erik P. Sulman

Brain and Spine Tumor Center, Laura and Isaac Perlmutter Cancer Center, New York, NY, United States

Erik P. Sulman

NYU Langone Health, New York, NY, United States

David D. Eisenstat

Section of Neuro-oncology & Neurosurgical Oncology, Frontiers in Oncology and Frontiers in Neurology, Lausanne, Switzerland

David D. Eisenstat

Children’s Cancer Centre, Royal Children’s Hospital, Parkville VIC, Australia

David D. Eisenstat

Stem Cell Biology, Murdoch Children’s Research Institute, Parkville, VIC, Australia

David D. Eisenstat

Department of Paediatrics, University of Melbourne, Parkville, VIC, Australia